| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.096 | 0.0006 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |